Projects overview

Sort by

Toggle all information

I-MOVE-plus | I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly

01-05-2015

-

31-10-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-17-2014 Comparing the effectiveness of existing healthcare interventions in the elderly

SITless | SITless: Exercise Referral Schemes enhanced by Self-Management Strategies to battle sedentary behaviour

01-05-2015

-

30-09-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-17-2014 Comparing the effectiveness of existing healthcare interventions in the elderly

DiaChemo | Point-of-care microfluidic device for quantification of chemotherapeutic drugs in small body fluid samples by highly selective nanoparticle extraction and liquid crystal detection

01-05-2015

-

31-10-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms

ULTRADIAN | Dynamic hormone diagnostics

01-09-2015

-

29-02-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms

CARBALIVE | Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.

01-05-2015

-

31-01-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-13-2014 New therapies for chronic non-communicable diseases

DIAGORAS | Chair/bedside diagnosis of oral and respiratory tract infections, and identification of antibiotic resistances for personalised monitoring and treatment

01-06-2015

-

31-05-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms

MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)

01-10-2015

-

30-11-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-13-2014 New therapies for chronic non-communicable diseases

MIROCALS | Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients

01-09-2015

-

30-09-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-13-2014 New therapies for chronic non-communicable diseases

EU-CaRE | A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly

01-05-2015

-

30-04-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-17-2014 Comparing the effectiveness of existing healthcare interventions in the elderly

REGAIN | REgeneration of inner ear hair cells with GAmma-secretase INhibitors to regain hearing in patients with sensorineural hearing loss

01-05-2015

-

31-10-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-13-2014 New therapies for chronic non-communicable diseases

GLORIA | Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis

01-09-2015

-

31-08-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-17-2014 Comparing the effectiveness of existing healthcare interventions in the elderly

FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone

01-05-2015

-

31-10-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-13-2014 New therapies for chronic non-communicable diseases

GLAM | Laser Multiplexed Biosensor

01-05-2015

-

30-04-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms

MDS-RIGHT | Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time

01-05-2015

-

31-10-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-17-2014 Comparing the effectiveness of existing healthcare interventions in the elderly

BETA3_LVH | A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease

01-05-2015

-

31-08-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-13-2014 New therapies for chronic non-communicable diseases

PHOCNOSIS | Advanced nanophotonic point-of-care analysis device for fast and early diagnosis of cardiovascular diseases

01-09-2015

-

28-02-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms

BeyondSeq | Genomic diagnostics beyond the sequence

01-05-2015

-

30-04-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms

FAPIC | Fast Assay for Pathogen Identification and Characterisation

01-05-2015

-

31-10-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms
Powered by Chris Decubber BV